<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ojrdrt</journal-id><journal-title-group><journal-title xml:lang="ru">Онкологический журнал: лучевая диагностика, лучевая терапия</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of oncology: diagnostic radiology and radiotherapy</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7593</issn><issn pub-type="epub">2713-167X</issn><publisher><publisher-name>НЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37174/2587-7593-2018-1-3-44-48</article-id><article-id custom-type="elpub" pub-id-type="custom">ojrdrt-33</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛУЧЕВАЯ ДИАГНОСТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DIAGNOSTIC RADIOLOGY</subject></subj-group></article-categories><title-group><article-title>Диффузионно-взвешенная магнитно-резонансная томография всего тела с оценкой измеряемого коэффициента диффузии при лимфоме Ходжкина</article-title><trans-title-group xml:lang="en"><trans-title>Whole-Body Diffusion-Weighted Magnetic Resonance Imaging with Assessment of Apparent Diffusion Coefficient in Hodgkin’s Lymphoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михайлов</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhaylov</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mdnadya@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панов</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Panov</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mdnadya@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мещерякова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Meshcheryakova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mdnadya@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пронин</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pronin</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mdnadya@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вихрова</surname><given-names>Н. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Vikhrova</surname><given-names>N. B.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mdnadya@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долгушин</surname><given-names>М. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolgushin</surname><given-names>M. B.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mdnadya@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российская медицинская академия непрерывного последипломного образования Минздрава РФ;&#13;
Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина Минздрава РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuing Postgraduate Education;&#13;
N.N. Blokhin National Medical Research Center of Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российская медицинская академия непрерывного последипломного образования Минздрава РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian Medical Academy of Continuing Postgraduate Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина Минздрава РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin National Medical Research Center of Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2018</year></pub-date><volume>1</volume><issue>3</issue><fpage>44</fpage><lpage>48</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Михайлов А.И., Панов В.О., Мещерякова Н.А., Пронин А.И., Вихрова Н.Б., Долгушин М.Б., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Михайлов А.И., Панов В.О., Мещерякова Н.А., Пронин А.И., Вихрова Н.Б., Долгушин М.Б.</copyright-holder><copyright-holder xml:lang="en">Mikhaylov A.I., Panov V.O., Meshcheryakova N.A., Pronin A.I., Vikhrova N.B., Dolgushin M.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.oncoradjournal.ru/jour/article/view/33">https://www.oncoradjournal.ru/jour/article/view/33</self-uri><abstract><sec><title>Цель</title><p>Цель: Определить возможность применения метода диффузно-взвешенной МРТ с определением измеряемого коэффициента (ИКД) для дифференциальной диагностики нормальных лимфатических узлов (ЛУ) от пораженных ЛУ у пациентов с лимфомой Ходжкина (ЛХ).</p></sec><sec><title>Материал и методы</title><p>Материал и методы: Для определения эффективности использования ИКД с целью дифференциации нормальных и пораженных ЛУ при ЛХ проведено сравнение значений ИКД ЛУ у 27 условно здоровых лиц и у 41 пациента с верифицированным диагнозом ЛХ.</p></sec><sec><title>Результаты</title><p>Результаты: Построение 95 %-х доверительных интервалов показало, что значения ИКД нормальных ЛУ находились в интервале от 1,00 до 1,73.10–3 мм2/с и были достоверно выше (p &lt; 0,05), чем у ЛУ, пораженных лимфоматозным процессом (ИКД от 0,59 до 0,94.10–3 с/мм2). Порог дискриминации нормальных и лимфоматозно-измененных ЛУ находился в интервале от 0,94 до 1,00.10–3 мм2/с. Таким образом ЛУ, имеющие ИКД ниже 0,94.10–3 мм2/с, можно считать пораженными лимфоматозным процессом.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: To determine the effectiveness of apparent diffusion coefficient (ADC) for the purpose of normal and diseased lymph nodes (LN) differentiation in HL by DWI MRI.</p></sec><sec><title>Material and methods</title><p>Material and methods: To determine the effectiveness of ADC for the purpose of normal and diseased LN differentiation in HL was compared ADC values of LN in 27 apparently healthy individuals and in 41 patients with verified HL.</p></sec><sec><title>Results</title><p>Results: 95 % confidence intervals showed that values of ADC in normal LN ranged from 1.00 to 1.73 . 10–3 s/mm2 and were significantly higher (p &lt; 0,05), than in LN affected by HL (ADC from 0.59 to 0.94 . 10–3 mm2/s). Cut off point of normal and lymphomatous-LN ranged from 0.94 to 1.00 . 10–3 mm2/s. Therefore, LN with ADC below 0.94 . 10–3 mm2/s could be interpreted as affected by HL.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>лимфома Ходжкина</kwd><kwd>МРТ</kwd><kwd>ПЭТ</kwd><kwd>МРТ всего тела</kwd><kwd>диффузия</kwd><kwd>диффузионно-взвешенно изображение</kwd><kwd>измеряемый коэффициент диффузии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Hodgkin’s lymphoma</kwd><kwd>MRI</kwd><kwd>PET</kwd><kwd>whole body MRI</kwd><kwd>diffusion</kwd><kwd>DWI</kwd><kwd>DWIBS</kwd><kwd>ADC</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Heidemann R.M., Ozsarlak O., Parizel P.M. et al. A brief review of parallel magnetic resonance imaging // Eur. Radiol. 2003. Vol. 13. № 10. Р. 2323–2337.</mixed-citation><mixed-citation xml:lang="en">Heidemann R.M., Ozsarlak O., Parizel P.M. et al. A brief review of parallel magnetic resonance imaging // Eur. Radiol. 2003. Vol. 13. № 10. Р. 2323–2337.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pruessmann K.P. Encoding and reconstruction in parallel // NMR in Biomedicine. 2006. Vol. 19. № 3. Р. 288–299.</mixed-citation><mixed-citation xml:lang="en">Pruessmann K.P. Encoding and reconstruction in parallel // NMR in Biomedicine. 2006. Vol. 19. № 3. Р. 288–299.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Pipe J.G. Motion correction with PROPELLER MRI: application to head motion and free-breathing cardiac imaging // Magn. Reson. Med. 1999. Vol. 42. № 5. Р. 963–969.</mixed-citation><mixed-citation xml:lang="en">Pipe J.G. Motion correction with PROPELLER MRI: application to head motion and free-breathing cardiac imaging // Magn. Reson. Med. 1999. Vol. 42. № 5. Р. 963–969.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kwee T.C., Takahara T., Vermoolen M.A. et al. Whole-body diffusion-weighted imaging for staging malignant lymphoma in children // Pediatric Radiol. 2010. Vol. 40. № 10. Р. 1592–1602.</mixed-citation><mixed-citation xml:lang="en">Kwee T.C., Takahara T., Vermoolen M.A. et al. Whole-body diffusion-weighted imaging for staging malignant lymphoma in children // Pediatric Radiol. 2010. Vol. 40. № 10. Р. 1592–1602.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Takahara T., Imai Y., Yamashita T. et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display // Matrix. 2004. Vol. 160. № 160. Р. 160.</mixed-citation><mixed-citation xml:lang="en">Takahara T., Imai Y., Yamashita T. et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display // Matrix. 2004. Vol. 160. № 160. Р. 160.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kwee T.C., Takahara T., Luijten P.R. et al. ADC measurements of lymph nodes: inter-and intra-observer reproducibility study and an overview of the literature // Eur. J. Radiol. 2010. Vol. 75. № 2. Р. 215–220.</mixed-citation><mixed-citation xml:lang="en">Kwee T.C., Takahara T., Luijten P.R. et al. ADC measurements of lymph nodes: inter-and intra-observer reproducibility study and an overview of the literature // Eur. J. Radiol. 2010. Vol. 75. № 2. Р. 215–220.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kwee T.C., Takahara T., Ochiai R. et al. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology // Eur. Radiol. 2008. Vol. 18. № 9. Р. 1937–1952.</mixed-citation><mixed-citation xml:lang="en">Kwee T.C., Takahara T., Ochiai R. et al. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology // Eur. Radiol. 2008. Vol. 18. № 9. Р. 1937–1952.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kwee T.C., Basu S., Torigian D.A. et al. Evolving importance of diffusion-weighted magnetic resonance imaging in lymphoma // PET Clinics. 2012. Vol. 7. № 1. Р. 73–82.</mixed-citation><mixed-citation xml:lang="en">Kwee T.C., Basu S., Torigian D.A. et al. Evolving importance of diffusion-weighted magnetic resonance imaging in lymphoma // PET Clinics. 2012. Vol. 7. № 1. Р. 73–82.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kwee T.C., van Ufford H.M.E.Q., Beek F.J. et al. Whole body magnetic resonance imaging, including diffusion weighted imaging, for diagnosing bone marrow involvement in malignant lymphoma // Brit. J. Haematol. 2010. Vol. 149. № 4. Р. 628–630.</mixed-citation><mixed-citation xml:lang="en">Kwee T.C., van Ufford H.M.E.Q., Beek F.J. et al. Whole body magnetic resonance imaging, including diffusion weighted imaging, for diagnosing bone marrow involvement in malignant lymphoma // Brit. J. Haematol. 2010. Vol. 149. № 4. Р. 628–630.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kwee T.C., Kwee R.M., Nievelstein R.A. Imaging in staging of malignant lymphoma: a systematic review // Blood. 2008. Vol. 111. №. 2. Р. 504–516.</mixed-citation><mixed-citation xml:lang="en">Kwee T.C., Kwee R.M., Nievelstein R.A. Imaging in staging of malignant lymphoma: a systematic review // Blood. 2008. Vol. 111. №. 2. Р. 504–516.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Van Ufford H.M.E., Kwee T.C., Beek F.J. et al. Whole body MRI, including diffusion-weighted imaging, compared to 18F-FDGPET-CT in newly diagnosed lymphoma: initial results // Amer. J. Roentgenol. 2011. № 196(3). Р. 662–669</mixed-citation><mixed-citation xml:lang="en">Van Ufford H.M.E., Kwee T.C., Beek F.J. et al. Whole body MRI, including diffusion-weighted imaging, compared to 18F-FDGPET-CT in newly diagnosed lymphoma: initial results // Amer. J. Roentgenol. 2011. № 196(3). Р. 662–669</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Vermoolen M.A., Kersten M.J., Fijnheer R. et al. Magnetic resonance imaging of malignant lymphoma // Expert Rev. Hematol. 2011. Vol. 4. № 2. Р. 161.</mixed-citation><mixed-citation xml:lang="en">Vermoolen M.A., Kersten M.J., Fijnheer R. et al. Magnetic resonance imaging of malignant lymphoma // Expert Rev. Hematol. 2011. Vol. 4. № 2. Р. 161.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Stejkal E.O., Tanner J.E. Spin diffusion measurements: spin echoes in the presence of a time‐dependent field gradient // J. Chem. Phys. 1965. Vol. 42. № 1. Р. 288–292.</mixed-citation><mixed-citation xml:lang="en">Stejkal E.O., Tanner J.E. Spin diffusion measurements: spin echoes in the presence of a time‐dependent field gradient // J. Chem. Phys. 1965. Vol. 42. № 1. Р. 288–292.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Le Bihan D., Breton E., Lallemand D. et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging // Radiology. 1988. Vol. 168. №. 2. Р. 497–505.</mixed-citation><mixed-citation xml:lang="en">Le Bihan D., Breton E., Lallemand D. et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging // Radiology. 1988. Vol. 168. №. 2. Р. 497–505.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Li S., Xue H., Li J. et al. Application of whole body diffusion weighted MR imaging for diagnosis and staging of malignant lymphoma // Chin. Med. Sci. J. 2008. Vol. 23. №. 3. Р. 138–144.</mixed-citation><mixed-citation xml:lang="en">Li S., Xue H., Li J. et al. Application of whole body diffusion weighted MR imaging for diagnosis and staging of malignant lymphoma // Chin. Med. Sci. J. 2008. Vol. 23. №. 3. Р. 138–144.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lin C., Itti E., Haioun C. et al. Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis // J. Nucl. Med. 2007. Vol. 48. № 10. Р. 1626–1632.</mixed-citation><mixed-citation xml:lang="en">Lin C., Itti E., Haioun C. et al. Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis // J. Nucl. Med. 2007. Vol. 48. № 10. Р. 1626–1632.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hayashida Y., Hirai T., Morishita S. et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity // Amer. J. Neuroradiol. 2006. Vol. 27. № 7. Р. 1419–1425.</mixed-citation><mixed-citation xml:lang="en">Hayashida Y., Hirai T., Morishita S. et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity // Amer. J. Neuroradiol. 2006. Vol. 27. № 7. Р. 1419–1425.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Schnapauff D., Zeile M., Niederhagen M.B. et al. Diffusionweighted echo‐planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft‐tissue sarcomas // J. Magn. Reson. Imaging. 2009. Vol. 29. № 6. Р. 1355– 1359.</mixed-citation><mixed-citation xml:lang="en">Schnapauff D., Zeile M., Niederhagen M.B. et al. Diffusionweighted echo‐planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft‐tissue sarcomas // J. Magn. Reson. Imaging. 2009. Vol. 29. № 6. Р. 1355– 1359.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sugahara T., Korogi Y., Kochi M. et al. Usefulness of diffusion weighted MRI with echo planar technique in the evaluation of cellularity in gliomas // J. Magn. Reson. Imaging. 1999. Vol. 9. № 1. Р. 53–60.</mixed-citation><mixed-citation xml:lang="en">Sugahara T., Korogi Y., Kochi M. et al. Usefulness of diffusion weighted MRI with echo planar technique in the evaluation of cellularity in gliomas // J. Magn. Reson. Imaging. 1999. Vol. 9. № 1. Р. 53–60.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Padhani A.R., Liu G., Mu-Koh D. et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations // Neoplasia. 2009. Vol. 11. № 2. Р. 102– 125.</mixed-citation><mixed-citation xml:lang="en">Padhani A.R., Liu G., Mu-Koh D. et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations // Neoplasia. 2009. Vol. 11. № 2. Р. 102– 125.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ioachim H.L., Medeiros L.J. Ioachim’s Lymph Node Pathology. – Lippincott Williams &amp; Wilkins, 2009.</mixed-citation><mixed-citation xml:lang="en">Ioachim H.L., Medeiros L.J. Ioachim’s Lymph Node Pathology. – Lippincott Williams &amp; Wilkins, 2009.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Holzapfel K., Duetsch S., Fauser C. et al. Value of diffusionweighted MR imaging in the differentiation between benign and malignant cervical lymph nodes // Eur. J. Radiol. 2009. Vol. 72. № 3. Р. 381–387.</mixed-citation><mixed-citation xml:lang="en">Holzapfel K., Duetsch S., Fauser C. et al. Value of diffusionweighted MR imaging in the differentiation between benign and malignant cervical lymph nodes // Eur. J. Radiol. 2009. Vol. 72. № 3. Р. 381–387.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">King A.D., Ahuja A.T., Yeung D.K.W. et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging 1 // Radiology. 2007. Vol. 245. № 3. Р. 806–813.</mixed-citation><mixed-citation xml:lang="en">King A.D., Ahuja A.T., Yeung D.K.W. et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging 1 // Radiology. 2007. Vol. 245. № 3. Р. 806–813.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Rahmouni A., Tempany C., Jones R. et al. Lymphoma: monitoring tumor size and signal intensity with MR imaging // Radiology. 1993. Vol. 188. № 2. Р. 445–451.</mixed-citation><mixed-citation xml:lang="en">Rahmouni A., Tempany C., Jones R. et al. Lymphoma: monitoring tumor size and signal intensity with MR imaging // Radiology. 1993. Vol. 188. № 2. Р. 445–451.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sumi M., Sakihama N., Sumi T. et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer/ // Amer. J. Neuroradiol. 2003. Vol. 24. №. 8. Р. 1627–1634.</mixed-citation><mixed-citation xml:lang="en">Sumi M., Sakihama N., Sumi T. et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer/ // Amer. J. Neuroradiol. 2003. Vol. 24. №. 8. Р. 1627–1634.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Sumi M., Van Cauteren M., Nakamura T. MR microimaging of benign and malignant nodes in the neck // Amer. J. Roentgenol. 2006. Vol. 186. № 3. Р. 749–757.</mixed-citation><mixed-citation xml:lang="en">Sumi M., Van Cauteren M., Nakamura T. MR microimaging of benign and malignant nodes in the neck // Amer. J. Roentgenol. 2006. Vol. 186. № 3. Р. 749–757.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Sumi M., Nakamura T. Diagnostic importance of focal defects in the apparent diffusion coefficient-based differentiation between lymphoma and squamous cell carcinoma nodes in the neck // Eur. Radiol. 2009. Vol. 19. № 4. Р. 975–981.</mixed-citation><mixed-citation xml:lang="en">Sumi M., Nakamura T. Diagnostic importance of focal defects in the apparent diffusion coefficient-based differentiation between lymphoma and squamous cell carcinoma nodes in the neck // Eur. Radiol. 2009. Vol. 19. № 4. Р. 975–981.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Lin C., Luciani A., Itti E. et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study // Invest. Radiol. 2011. Vol. 46. № 5. Р. 341–349.</mixed-citation><mixed-citation xml:lang="en">Lin C., Luciani A., Itti E. et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study // Invest. Radiol. 2011. Vol. 46. № 5. Р. 341–349.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Koh D.M., Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology/ // Amer. J. Roentgenol. 2007. Vol. 188. № 6. Р. 1622–1635.</mixed-citation><mixed-citation xml:lang="en">Koh D.M., Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology/ // Amer. J. Roentgenol. 2007. Vol. 188. № 6. Р. 1622–1635.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Torabi M., Aquino S.L., Harisinghani M.G. et al. Current concepts in lymph node imaging // J. Nucl. Med. 2004. Vol. 45. № 9. Р. 1509–1518.</mixed-citation><mixed-citation xml:lang="en">Torabi M., Aquino S.L., Harisinghani M.G. et al. Current concepts in lymph node imaging // J. Nucl. Med. 2004. Vol. 45. № 9. Р. 1509–1518.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Cheson B.D., Fisher R.I., Barrington S.F. et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification // J. Clin. Oncol. 2014. С. JCO. 2013.54. 8800.</mixed-citation><mixed-citation xml:lang="en">Cheson B.D., Fisher R.I., Barrington S.F. et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification // J. Clin. Oncol. 2014. С. JCO. 2013.54. 8800.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Willinek W.A., Gieseke J., Kukuk G. Parallel RF transmission in body MRI for reduced dielectric shading, improved B1 homogeneity and accelerated imaging at 3.0 T: Initial clinical experience in 40 patients using MultiTransmit. – ISMRM 17th Sci. Meet. &amp; Exhibition, Honolulu, Hawai’i, USA. 2009.</mixed-citation><mixed-citation xml:lang="en">Willinek W.A., Gieseke J., Kukuk G. Parallel RF transmission in body MRI for reduced dielectric shading, improved B1 homogeneity and accelerated imaging at 3.0 T: Initial clinical experience in 40 patients using MultiTransmit. – ISMRM 17th Sci. Meet. &amp; Exhibition, Honolulu, Hawai’i, USA. 2009.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Takahara T., Zwanenburg J., Visser F. et al. Fat suppression with slice-selection gradient reversal (SSGR) revisited. – ISMRM 17th Sci. Meet. &amp; Exhibition, Honolulu, Hawai’i, USA. 2009.</mixed-citation><mixed-citation xml:lang="en">Takahara T., Zwanenburg J., Visser F. et al. Fat suppression with slice-selection gradient reversal (SSGR) revisited. – ISMRM 17th Sci. Meet. &amp; Exhibition, Honolulu, Hawai’i, USA. 2009.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Thoeny H.C., Triantafyllou M., Birkhaeuser F.D. et al. Combined ultrasmall superparamagnetic particles of iron oxide–enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients // Europ. Urol. 2009. Vol. 55. № 4. Р. 761–769.</mixed-citation><mixed-citation xml:lang="en">Thoeny H.C., Triantafyllou M., Birkhaeuser F.D. et al. Combined ultrasmall superparamagnetic particles of iron oxide–enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients // Europ. Urol. 2009. Vol. 55. № 4. Р. 761–769.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Von Schulthess G.K., Schlemmer H.P.W. A look ahead: PET/ MR versus PET/CT // Europ. J. Nucl. Med. and Molec. Imaging. 2009. Vol. 36. № 1. Р. 3–9.</mixed-citation><mixed-citation xml:lang="en">Von Schulthess G.K., Schlemmer H.P.W. A look ahead: PET/ MR versus PET/CT // Europ. J. Nucl. Med. and Molec. Imaging. 2009. Vol. 36. № 1. Р. 3–9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
